Skip to content

Clinical trials

Phase 2 Down Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Down Syndrome Phase: Phase 2 Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20101
20122
20132
20142
20151
20162
20171
20181
20203
20212
20221
20235
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting9
Withdrawn3
Active, not recruiting2
Terminated2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Colorado, Denver4
Eisai Inc.2
Hoffmann-La Roche2
Ohio State University2
Parc de Salut Mar2
University of Arizona2
AC Immune SA1
Aelis Farma1
Alnylam Pharmaceuticals1
Asklepieion Voulas General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Down Syndrome33
Sleep Apnea, Obstructive3
Alopecia Areata2
Alzheimer Disease2
Autoimmune Diseases2
Cognitive Dysfunction2
Dermatitis, Atopic2
Autoimmune Diseases of the Nervous System1
Burkitt Lymphoma1
Catatonia1

Trials

Showing 26 to 33 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.